Cardiology at Renji Hospital Shanghai | CMCS

Expert Heart Disease Care at One of Shanghai's Premier Hospitals

The Department of Cardiology at Renji Hospital — affiliated with Shanghai Jiao Tong University School of Medicine — is one of Shanghai's most distinguished cardiology centers, with a national reputation for excellence in interventional cardiology, structural heart disease, heart failure, cardiac electrophysiology, and the management of complex cardiovascular conditions. The department combines outstanding clinical expertise with a world-class research program and a fully integrated multidisciplinary approach, offering international patients access to some of China's most eminent cardiologists and the latest evidence-based treatments and interventional techniques.

For international patients with coronary artery disease, heart failure, structural heart disease, arrhythmias, or a complex cardiovascular condition — Renji Hospital's cardiology department offers an unparalleled combination of clinical expertise, interventional capability, and research leadership. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their cardiac care journey at Renji Hospital.

About the Department

Renji Hospital's cardiology department is a national key clinical specialty operating dedicated cardiac care wards, a coronary care unit (CCU), multiple cardiac catheterization laboratories, an electrophysiology laboratory, an echocardiography laboratory, a cardiac imaging center, a heart failure clinic, a structural heart disease program, and works in close collaboration with cardiac surgery, vascular surgery, and critical care through a fully integrated multidisciplinary team.

Faculty members publish regularly in leading cardiology journals including Journal of the American College of Cardiology, Circulation, European Heart Journal, JACC: Cardiovascular Interventions, and Heart Rhythm.

Conditions Treated

Coronary Artery Disease (CAD)

• Stable Coronary Artery Disease — Optimal medical therapy (aspirin, statins, beta-blockers, ACE inhibitors/ARBs); fractional flow reserve (FFR) and iFR-guided revascularization decisions; PCI with drug-eluting stents; CABG coordination for complex multivessel disease
• Acute Coronary Syndromes (ACS) — Primary PCI for STEMI (door-to-balloon time optimization); radial access PCI; drug-eluting stent implantation; dual antiplatelet therapy (DAPT) optimization; prasugrel and ticagrelor; cangrelor for bridging
• Complex PCI — Left main PCI; bifurcation PCI (two-stent techniques); chronic total occlusion (CTO) PCI; calcified lesion PCI with rotational atherectomy and intravascular lithotripsy (IVL); intravascular imaging-guided PCI (IVUS, OCT)
• Refractory Angina — Enhanced external counterpulsation (EECP); coronary sinus reducer; spinal cord stimulation
• Post-ACS Management — Cardiac rehabilitation; PCSK9 inhibitors (evolocumab, alirocumab) for LDL reduction; inclisiran; icosapentaenoic acid (Vascepa) for residual cardiovascular risk

Heart Failure

• Heart Failure with Reduced Ejection Fraction (HFrEF) — Quadruple therapy: ACE inhibitor/ARB/ARNI (sacubitril/valsartan) + beta-blocker + MRA (spironolactone/eplerenone) + SGLT2 inhibitor (dapagliflozin/empagliflozin); ivabradine for elevated heart rate; hydralazine + nitrates for ACE inhibitor-intolerant patients
• Heart Failure with Preserved Ejection Fraction (HFpEF) — SGLT2 inhibitors (empagliflozin, dapagliflozin); spironolactone; blood pressure control; weight management; finerenone
• Advanced Heart Failure — Inotropic support (dobutamine, milrinone, levosimendan); mechanical circulatory support (IABP, Impella, ECMO); cardiac resynchronization therapy (CRT); ICD; left ventricular assist device (LVAD) evaluation; cardiac transplantation evaluation
• Cardiogenic Shock — Impella CP and 5.5 for hemodynamic support; VA-ECMO; early revascularization; multidisciplinary shock team
• Cardiac Amyloidosis — Tafamidis for ATTR-CM (wild-type and hereditary); acoramidis; eplontersen and patisiran for hereditary ATTR; technetium pyrophosphate (PYP) scan for ATTR diagnosis; daratumumab for AL amyloidosis
• Hypertrophic Cardiomyopathy (HCM) — Beta-blockers and disopyramide; mavacamten (cardiac myosin inhibitor) for obstructive HCM; aficamten; alcohol septal ablation; surgical myectomy coordination; ICD for SCD prevention
• Dilated Cardiomyopathy — Guideline-directed medical therapy; genetic testing (TTN, LMNA, SCN5A); LMNA-DCM: ICD for sudden death prevention

Structural Heart Disease

• Transcatheter Aortic Valve Replacement (TAVR) — TAVR for severe aortic stenosis in high, intermediate, and low surgical risk patients; transfemoral approach; valve-in-valve TAVR for failed bioprostheses; one of Shanghai's most experienced TAVR programs
• Transcatheter Mitral Valve Repair (MitraClip/TEER) — Edge-to-edge repair for primary and secondary mitral regurgitation; COAPT trial criteria for functional MR
• Transcatheter Tricuspid Valve Interventions — Tricuspid TEER (TriClip); EVOQUE transcatheter tricuspid valve replacement
• Left Atrial Appendage Closure (LAAC) — Watchman FLX and Amulet for AF patients with contraindication to anticoagulation; stroke prevention
• Patent Foramen Ovale (PFO) Closure — Transcatheter PFO closure for cryptogenic stroke; Amplatzer PFO Occluder
• Hypertrophic Obstructive Cardiomyopathy (HOCM) — Alcohol septal ablation; surgical myectomy coordination
• Pulmonary Valve Interventions — Transcatheter pulmonary valve replacement (Melody, SAPIEN) for conduit dysfunction

Cardiac Electrophysiology

• Atrial Fibrillation (AF) — Rate and rhythm control; pulmonary vein isolation (PVI) by radiofrequency and cryoablation; pulsed field ablation (PFA) for AF; left atrial appendage closure; cardioversion; antiarrhythmic drugs (flecainide, propafenone, amiodarone, dronedarone, sotalol)
• Atrial Flutter — Cavotricuspid isthmus (CTI) ablation; cardioversion
• Supraventricular Tachycardia (SVT) — AVNRT and AVRT ablation; WPW syndrome ablation
• Ventricular Tachycardia (VT) — Catheter ablation for scar-related and idiopathic VT; epicardial ablation; antiarrhythmic drugs; ICD programming optimization
• Ventricular Fibrillation & Sudden Cardiac Death — ICD implantation; subcutaneous ICD (S-ICD); wearable cardioverter-defibrillator (WCD); genetic testing for channelopathies
• Bradyarrhythmias — Permanent pacemaker implantation; His bundle pacing and left bundle branch area pacing (LBBAP) for physiological pacing; leadless pacemaker (Micra)
• Cardiac Resynchronization Therapy (CRT) — CRT-P and CRT-D for heart failure with dyssynchrony; conduction system pacing as alternative to biventricular pacing
• Inherited Arrhythmia Syndromes — Long QT syndrome; Brugada syndrome; CPVT; short QT syndrome; genetic testing and family screening

Valvular Heart Disease

• Aortic Stenosis — TAVR for high/intermediate/low risk; surgical AVR coordination; balloon aortic valvuloplasty as bridge
• Mitral Regurgitation — MitraClip TEER; surgical repair coordination; medical optimization
• Mitral Stenosis — Percutaneous mitral balloon valvuloplasty (PMBV) for rheumatic MS; surgical commissurotomy coordination
• Tricuspid Regurgitation — Transcatheter tricuspid interventions; surgical repair coordination
• Aortic Regurgitation — Medical management; TAVR for AR (ALIGN-AR trial); surgical AVR coordination

Pulmonary Hypertension

• Pulmonary Arterial Hypertension (PAH) — Vasoreactivity testing; ERA (bosentan, macitentan, ambrisentan) + PDE5i (sildenafil, tadalafil) + prostacyclin (selexipag, iloprost, IV epoprostenol); sotatercept (activin receptor ligand trap) for PAH; riociguat for CTEPH
• Chronic Thromboembolic PH (CTEPH) — Riociguat; balloon pulmonary angioplasty (BPA); pulmonary endarterectomy coordination

Aortic Disease

• Aortic Aneurysm — Surveillance; TEVAR for descending thoracic aortic aneurysm; EVAR for abdominal aortic aneurysm; open surgical repair coordination
• Aortic Dissection — Type A: emergency surgical repair coordination; Type B: medical management; TEVAR for complicated Type B

Cardiac Imaging Program

• Echocardiography — Transthoracic (TTE) and transesophageal (TEE) echocardiography; 3D echocardiography; stress echocardiography; intracardiac echocardiography (ICE) for procedural guidance
• Cardiac CT — Coronary CT angiography (CCTA); TAVR planning CT; structural heart disease planning
• Cardiac MRI — Myocardial viability; cardiomyopathy characterization; cardiac amyloidosis; myocarditis
• Nuclear Cardiology — Myocardial perfusion imaging; PYP scan for ATTR amyloidosis; FDG-PET for cardiac sarcoidosis

Why International Patients Choose Renji Cardiology

• TAVR Expertise — One of Shanghai's most experienced TAVR programs for severe aortic stenosis
• Pulsed Field Ablation (PFA) — Latest-generation AF ablation technology for superior pulmonary vein isolation
• Cardiac Amyloidosis Program — Tafamidis, acoramidis, and eplontersen for ATTR-CM; PYP scan diagnosis
• HCM Expertise — Mavacamten and aficamten for obstructive HCM; alcohol septal ablation
• Sotatercept for PAH — Novel activin receptor ligand trap for pulmonary arterial hypertension
• Cost-Effectiveness — World-class cardiac care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your cardiac diagnosis, ECG, echocardiography reports, cardiac catheterization data, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate cardiologist based on your condition — interventional cardiology, structural heart disease, heart failure, electrophysiology, or pulmonary hypertension.
4. MDT Submission — Where appropriate, we facilitate pre-arrival case review by Renji's cardiac MDT (Heart Team).
5. Priority Scheduling — We secure a consultation with minimal waiting time.
6. Travel & Logistics — Assistance with visa invitation letters, accommodation near Renji Hospital, and Shanghai airport transfers.
7. Procedural Coordination — Full coordination of cardiac catheterization, TAVR, ablation, device implantation, or other cardiac procedures.
8. Post-Procedure Follow-Up — Procedure report translation, medication guidance, and remote follow-up coordination after you return home.

Book a Consultation

If you have coronary artery disease, heart failure, structural heart disease, an arrhythmia, or a complex cardiovascular condition — CMCS can arrange a specialist consultation with Renji Hospital's cardiology team in Shanghai.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com